Analyst Travis Steed of Bank of America Securities maintained a Hold rating on Solventum Corporation, retaining the price target of $85.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Travis Steed has given his Hold rating due to a combination of factors related to Solventum’s position in healthcare IT and its broader turnaround story post separation. He notes that while healthcare IT contributes meaningfully to both revenue and operating profit, the company does not expect new large language model launches to materially change its financial outlook in the near term, and he is not yet convinced this segment will be a core long-term growth engine despite shifting peer valuations.
At the same time, Steed highlights that Solventum has built a differentiated, hybrid AI approach in revenue cycle management and related HCIT subsegments that appears defensible versus generic LLM-based offerings, supporting the current valuation but not clearly justifying an upgrade. With the stock trading below, yet not dramatically distant from, his price objective and the company still in the early stages of executing a broader corporate turnaround, he sees a balanced risk-reward profile that warrants maintaining a Neutral stance rather than a more decisively bullish or bearish rating.